The high demand for semaglutide and tirzepatide has led to an increase in the availability of many non-FDA-approved compounded peptides
Enhances Metabolism Lipotropic agents (MIC) help the liver break down and process fat more effectively, supporting metabolic health and body composition
With surgeon approval, PDA-class peptides could be positioned as an adjunct to ERAS-style pathways, not a replacement for evidence-based analgesia, infection prevention, or VTE prophylaxis, and discussed with attention to dosing, timing, and route
Many users report noticeable pain reduction within just 1-2 weeks of starting treatment, with continued improvements throughout their protocol
By reducing levels of these mediators, cold therapy creates conditions more favorable for tissue preservation
Sterility failures and manufacturing impurities Another major concern when it comes to peptides is manufacturing quality